MedPath

江西康恩贝天施康药业有限公司

Ownership
-
Established
2002-12-31
Employees
-
Market Cap
-
Website
http://www.herbi-sky.com.cn

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

206

NMPA:206

Drug Approvals

复方鱼腥草滴丸

Approval Number
国药准字Z20090703
Approval Date
Mar 5, 2024
NMPA

肿节风胶囊

Approval Number
国药准字Z20080522
Approval Date
Feb 28, 2023
NMPA

根痛平胶囊

Approval Number
国药准字Z20080356
Approval Date
Jan 22, 2023
NMPA

Paracetamol,Caffein,Atificial Cow-bezoar and Chlorphenamine Maleate Capsules

Product Name
氨咖黄敏胶囊
Approval Number
国药准字H36022067
Approval Date
Jul 19, 2022
NMPA

复方丹参片

Approval Number
国药准字Z36021094
Approval Date
Jul 18, 2022
NMPA

感冒清片

Approval Number
国药准字Z36021525
Approval Date
Jul 18, 2022
NMPA

Sterile Water for Injection

Product Name
灭菌注射用水
Approval Number
国药准字H36021766
Approval Date
Jul 17, 2022
NMPA

Benzyl Alcohol Injection

Product Name
苯甲醇注射液
Approval Number
国药准字H36021623
Approval Date
Jul 17, 2022
NMPA

Sterile Water for Injection

Product Name
灭菌注射用水
Approval Number
国药准字H36021767
Approval Date
Jul 17, 2022
NMPA

复方大青叶注射液

Approval Number
国药准字Z36020690
Approval Date
Jul 17, 2022
NMPA
  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 21
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.